Mode
Text Size
Log in / Sign up

Elevated neutrophil-to-lymphocyte ratio correlates with higher mortality in rheumatoid arthritisHigher blood cell ratio linked to increased mortality risk in rheumatoid arthritis patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret elevated NLR in RA as a correlated prognostic marker, not a causal risk factor.

This meta-analysis pooled data from seven observational studies to examine the association between neutrophil-to-lymphocyte ratio (NLR) and prognosis in patients with rheumatoid arthritis. The analysis specifically assessed the correlation between elevated NLR and all-cause mortality. The study setting and follow-up duration were not reported. No comparator group was specified in the analysis.

The primary finding was that elevated NLR showed a significant correlation with higher all-cause mortality, with an odds ratio of 1.70 (95% confidence interval: 1.39 to 2.09). Absolute numbers for mortality events were not reported. No secondary outcomes were analyzed in this meta-analysis. The evidence was graded using the GRADE system, though the specific quality rating was not provided.

Safety and tolerability data were not reported. The authors explicitly noted this analysis demonstrates correlation, not causation. Key limitations include the observational nature of all included studies and the relatively small number of studies (seven) available for pooling. Funding sources and conflicts of interest were not reported.

For clinical practice, this meta-analysis suggests NLR may have potential as a prognostic marker in rheumatoid arthritis, but its application remains uncertain. The evidence is derived solely from observational associations, and the analysis does not establish that NLR modification would alter outcomes. Further prospective research is needed to determine if NLR measurement should influence clinical decision-making.

Researchers analyzed data from seven previous studies to understand whether a simple blood test measurement called the neutrophil-to-lymphocyte ratio (NLR) is connected to the long-term health of people with rheumatoid arthritis. The NLR is calculated from a standard complete blood count and reflects the balance between two types of white blood cells. The analysis included patients with rheumatoid arthritis, though the specific number of people and their follow-up time were not detailed in the summary.

The main finding was that patients with a higher NLR had a significantly greater risk of dying from any cause. The data showed their odds of death were about 70% higher compared to those with a lower ratio. The statistical confidence interval (1.39-2.09) supports this link, meaning the finding is unlikely to be due to chance. No specific safety concerns from having a high NLR were reported in this analysis.

It is crucial to understand that this study shows a correlation or link, not a cause. A high NLR doesn't necessarily cause death; it might be a marker of more severe inflammation or other health problems. The evidence comes from pooling observational studies, which can only show associations. The review was limited to just seven studies, so the finding needs confirmation in larger, more detailed research. For now, this information is primarily for researchers and doctors to consider, not something patients should act on without consulting their healthcare team.

What this means for you:
A high blood cell ratio is linked to higher death risk in RA, but this is an early finding that needs more study.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BackgroundRheumatoid arthritis (RA) is an autoimmune disease characterized by chronic systemic inflammation, posing a high risk of death, particularly from cardiovascular events. Finding simple and cost-effective prognostic biomarkers is crucial for risk stratification and improved patient management. The neutrophil-to-lymphocyte ratio (NLR), as a systemic inflammatory marker, has shown prognostic value in various diseases, but its comprehensive evidence in RA remains unclear.MethodsFollowing the PRISMA 2020 guidelines, relevant literature up to October 2025 was systematically searched in PubMed, Embase, Web of Science, and Cochrane databases. Observational studies were included. Random-effects models were used to pool odds ratios (OR) and 95% confidence intervals (CI). Robustness and publication bias were assessed using heterogeneity tests (I²), sensitivity analyses, and Egger’s tests. Evidence quality was graded using the GRADE system.ResultsOverall, seven studies were analyzed, and the meta-analytic findings indicated that elevated NLR was significantly correlated with all-cause mortality (OR = 1.70, 95%CI: 1.39-2.09, P
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.